FF
MIRM icon

FourThought Financial’s Mirum Pharmaceuticals MIRM Stock Holding History

FourThought Financial’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$16K Sell
780
-429
-35% -$10.3K ﹤0.01% 921
2022
Q2 		$24K Hold
1,209
– – ﹤0.01% 820
2022
Q1 		$27K Buy
1,209
+205
+20% +$4.18K ﹤0.01% 832
2021
Q4 		$16K Buy
+1,004
New +$15.6K ﹤0.01% 974

Other funds holding MIRM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

FourThought Financial's MIRM Position: Q3 2022 in Review

FourThought Financial reduced its Mirum Pharmaceuticals (MIRM) stake by 35% in Q3 2022, selling an estimated $10.3K and leaving 780 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #921.

FourThought Financial first reported a position in MIRM in Q4 2021 and has held it in 4 quarters since. The position peaked at $27K in Q1 2022. 112 funds tracked by Wall St. Rank hold MIRM as of Q3 2022.

  • FourThought Financial held 780 shares of Mirum Pharmaceuticals worth $16K as of Q3 2022.
  • FourThought Financial sold 429 Mirum Pharmaceuticals shares in Q3 2022, an estimated $10.3K.
  • Mirum Pharmaceuticals made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #921 holding.
  • FourThought Financial first reported a position in Mirum Pharmaceuticals in Q4 2021 and has held it in 4 quarters since.
  • FourThought Financial's Mirum Pharmaceuticals position peaked at $27K in Q1 2022.
  • 112 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.